Richard W. Paul & Associates LLC Purchases 20 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Richard W. Paul & Associates LLC grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 1.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,417 shares of the medical equipment provider’s stock after purchasing an additional 20 shares during the quarter. Richard W. Paul & Associates LLC’s holdings in Intuitive Surgical were worth $740,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the company. M.E. Allison & CO. Inc. bought a new position in Intuitive Surgical during the fourth quarter valued at approximately $449,000. Seilern Investment Management Ltd purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at $82,517,000. Sycomore Asset Management grew its holdings in shares of Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after purchasing an additional 4,079 shares during the last quarter. Exome Asset Management LLC raised its position in Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. lifted its stake in Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 2,401 shares of Intuitive Surgical stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the completion of the transaction, the executive vice president now owns 353 shares in the company, valued at approximately $205,093. The trade was a 87.18 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 8,077 shares of company stock valued at $4,620,025 in the last three months. Company insiders own 0.80% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of recent research reports. Evercore ISI raised their price objective on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Leerink Partners boosted their price objective on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Wells Fargo & Company increased their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Bernstein Bank lifted their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Read Our Latest Stock Analysis on ISRG

Intuitive Surgical Trading Up 1.7 %

Shares of ISRG stock opened at $573.15 on Friday. The company’s fifty day moving average price is $569.87 and its 200-day moving average price is $528.64. The stock has a market cap of $204.14 billion, a PE ratio of 89.42, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Articles

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.